Filing Details
- Accession Number:
- 0000899243-17-013113
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-15 16:49:02
- Reporting Period:
- 2017-05-12
- Filing Date:
- 2017-05-15
- Accepted Time:
- 2017-05-15 16:49:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1631650 | Aimmune Therapeutics Inc. | AIMT | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1197350 | Eric Bjerkholt | Aimmune Therapeutics, Inc. 8000 Marina Boulevard, Suite 300 Brisbane CA 94005-1884 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 Par Value | Acquisiton | 2017-05-12 | 5,000 | $19.84 | 5,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- This transaction was executed in multiple trades in prices ranging from $19.83 to $19.85, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote.
Billionaire Hedge Funds
